atovaquone has been researched along with Plasmodium vivax Malaria in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Boelle, PY; Jauréguiberry, S; Kendjo, E; Le Goff, M; Piarroux, R; Thellier, M | 1 |
| Abate, A; Dembele, L; Diakite, O; Djimde, AA; Golassa, L; Kedir, S; Maiga, M; Sogore, F; Tandina, F | 1 |
| Meltzer, E; Rahav, G; Schwartz, E | 1 |
| Burrow, R; Chis Ster, I; Kremsner, PG; Krishna, S; Staines, HM; Teo, BH | 1 |
| Beerahee, M | 1 |
| David, K; Møller, CH | 1 |
| Adams, JH; Amedeo, P; Angiuoli, SV; Barnwell, JW; Bidwell, SL; Caler, E; Carlton, JM; Cheng, Q; Coulson, RM; Crabb, BS; Crabtree, J; Del Portillo, HA; Essien, K; Feldblyum, TV; Fernandez-Becerra, C; Fraser-Liggett, CM; Galinski, MR; Gardner, MJ; Gilson, PR; Gueye, AH; Guo, X; Hoffman, SL; Kang'a, S; Kooij, TW; Korsinczky, M; Lorenzi, H; Merino, EF; Meyer, EV; Nene, V; Paulsen, I; Ralph, SA; Ren, Q; Salzberg, SL; Sargeant, TJ; Silva, JC; Stoeckert, CJ; Sullivan, SA; White, O; Wortman, JR; Yamamoto, MM | 1 |
| Terlouw, DJ; van Eijk, AM | 1 |
| Arguin, PM; Magill, AJ; Steinhardt, LC | 1 |
| Kikuchi, T; Kimura, M; Koga, M; Maruyama, H; Miura, T | 1 |
| Lever, AM; Mavrogordato, A | 1 |
| Baird, JK; Bangs, MJ; Barcus, MJ; Chulay, JD; Fryauff, DJ; Gramzinski, R; Hoffman, SL; Jones, TR; Kumusumangsih, M; Lacy, M; Ling, J; Maguire, JD; Miller, GB; Sismadi, P | 1 |
| Baird, JK; Bangs, MJ; Barcus, MJ; Basri, H; Chulay, JD; Fryauff, DJ; Gramzinski, R; Hoffman, SL; Lacy, MD; Ling, J; Maguire, JD; Miller, GB; Sismadi, P | 1 |
| Barrett, PH; Davis, TM; Ilett, KF; Syed, DA | 1 |
| Armitage, KB; Blossom, DB; King, CH | 1 |
| World, MJ | 1 |
4 review(s) available for atovaquone and Plasmodium vivax Malaria
| Article | Year |
|---|---|
Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
Topics: Atovaquone; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Electron Transport Complex III; Humans; Malaria, Falciparum; Malaria, Vivax; Mutation; Plasmodium falciparum; Proguanil; Travel; Treatment Failure | 2018 |
Clinical pharmacology of atovaquone and proguanil hydrochloride.
Topics: Animals; Antimalarials; Atovaquone; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Activation; Humans; Intestinal Absorption; Intestinal Mucosa; Lymphocytes; Malaria; Malaria, Falciparum; Malaria, Vivax; Proguanil | 1999 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Review: Malaria chemoprophylaxis for travelers to Latin America.
Topics: Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Humans; Latin America; Malaria; Malaria, Vivax; Plasmodium vivax; Primaquine; Proguanil; Travel | 2011 |
2 trial(s) available for atovaquone and Plasmodium vivax Malaria
| Article | Year |
|---|---|
Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Chemoprevention; Child; Double-Blind Method; Female; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Plasmodium vivax; Proguanil; Transients and Migrants; Treatment Outcome | 2002 |
Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthoquinones; Plasmodium falciparum; Plasmodium vivax; Proguanil; Treatment Outcome | 2002 |
10 other study(ies) available for atovaquone and Plasmodium vivax Malaria
| Article | Year |
|---|---|
Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients.
Topics: Antimalarials; Atovaquone; Case-Control Studies; Chemoprevention; Chloroquine; Humans; Malaria; Malaria, Vivax; Plasmodium ovale; Plasmodium vivax; Travel | 2023 |
Ethiopian Plasmodium vivax hypnozoites formation dynamics and their susceptibility to reference antimalarial drugs.
Topics: Antimalarials; Atovaquone; Humans; Malaria, Vivax; Mali; Plasmodium vivax | 2023 |
Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options.
Topics: Adult; Aged; Antigens, Protozoan; Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Vivax; Male; Middle Aged; Proguanil; Retrospective Studies; Travel; Young Adult | 2018 |
Imported malaria is stable from Africa but declining from Asia.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Asia; Atovaquone; Chemoprevention; Child; Child, Preschool; Chloroquine; Delayed Diagnosis; Denmark; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Primaquine; Proguanil; Recurrence; Risk Factors; Severity of Illness Index; Travel; Young Adult | 2014 |
Comparative genomics of the neglected human malaria parasite Plasmodium vivax.
Topics: Amino Acid Motifs; Animals; Artemisinins; Atovaquone; Cell Nucleus; Chromosomes; Conserved Sequence; Erythrocytes; Evolution, Molecular; Genome, Protozoan; Genomics; Haplorhini; Humans; Isochores; Ligands; Malaria, Vivax; Multigene Family; Plasmodium vivax; Sequence Analysis, DNA; Species Specificity; Synteny | 2008 |
Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
Topics: Adult; Antimalarials; Atovaquone; Child, Preschool; Drug Combinations; Female; Humans; Infant; Japan; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Proguanil; Treatment Outcome | 2012 |
A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antimalarials; Atovaquone; Cohort Studies; Drug Combinations; Ethiopia; Humans; Incidence; Malaria, Vivax; Middle Aged; Proguanil; Surveys and Questionnaires; Travel; Treatment Outcome | 2012 |
Toxicity related to chloroquine treatment of resistant vivax malaria.
Topics: Adult; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Overdose; Humans; Malaria, Vivax; Male; Naphthoquinones; Plasmodium vivax; Primaquine; Proguanil | 2003 |
Occult Plasmodium vivax infection diagnosed by a polymerase chain reaction-based detection system: a case report.
Topics: Adult; Animals; Antimalarials; Atovaquone; Drug Therapy, Combination; Eye Infections, Parasitic; Female; Humans; Malaria, Vivax; Naphthoquinones; Plasmodium vivax; Polymerase Chain Reaction; Proguanil; Travel; Treatment Outcome; Zambia | 2005 |
Malaria remains a military medical problem.
Topics: Adult; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Global Health; Humans; Kenya; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Medicine; Military Personnel; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Plasmodium vivax; Proguanil; Sierra Leone; Treatment Failure; Treatment Outcome; United Kingdom | 2001 |